Inhibitory Effect of Heparin on Serotonin-induced Hyperplasia and Hypertrophy of Smooth Muscle Cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 17, Issue 1, 1997, Pages 78-83

  Lee, Sheu Ling ^a   Wang, Wei Wei ^b   Joseph, Patricia M ^b   Hales, Charles A ^b   Fanburg, Barry L ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOVINAE;

DNA; HEPARIN; SEROTONIN; SEROTONIN ANTAGONIST; THYMIDINE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CATTLE; CELL CULTURE; CELL DIVISION; DRUG EFFECT; HYPERPLASIA; HYPERTROPHY; KINETICS; METABOLISM; PATHOLOGY; PULMONARY ARTERY; TRANSPORT AT THE CELLULAR LEVEL; VASCULAR SMOOTH MUSCLE;

ANIMALS; BIOLOGICAL TRANSPORT; CATTLE; CELL DIVISION; CELLS, CULTURED; DNA; HEPARIN; HYPERPLASIA; HYPERTROPHY; KINETICS; MUSCLE, SMOOTH, VASCULAR; PULMONARY ARTERY; SEROTONIN; SEROTONIN ANTAGONISTS; THYMIDINE;

EID: 0031180790     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.17.1.2727     Document Type: Article

References (47)

1. Clowes, A. W., and M. J. Karnovsky. 1977. Supression hy heparin of smooth muscle cell proliferation in injured arteries. Nature 265:625-626.
2. Guyton, J. R., R. D. Rosenberg, A. W. Clowes, and M. J. Karnovsky. 1980. Inhibition of rat arterial smooth muscle cell proliferation by heparin. Circ. Res. 46:625-634.
3. Hoover, R. L., R. Rosenberg, W. Hearing, and M. J. Karnovsky. 1980. Inhibition of rat arterial smooth muscle cell proliferation by heparin. II. In vitro studies. Circ Res. 47:578-583.
4. Thompson, B. T., C. R. Spence, S. P. Janssens, P. M. Joseph, and C. A. Hales. 1994. Inhibition of hypoxic pulmonary hypertension by heparins of differing in vitro antiproliferative potency. Am. J. Respir. Crit. Care Med. 149:1512-1517.
5. Castellot, J. J., Jr., L. V. Favreau, M. J. Karnovsky, and R. D. Rosenberg. 1982. Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin: possible role of a platelet endoglycosidase. J. Biol. Chem. 257:11256-11260.
6. Groggel, G. C., G. N. Marinides, P. Hovingh, E. Hammond, and A. Linker. 1990. Inhibition of rat mesangial cell growth by heparan sulfate. Am. J. Physiol. 258:F259-F265.
7. Floege, J., H. Eng, B. A. Young, W. G. Couser, and R. J. Johnson. 1993. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int. 43:369-380.
8. Wright, T. C., Jr., T. V. Johnstone, J. J. Castellot, Jr., and M. J. Karnovsky. 1985. Inhibition of rat cervical epithelial cell growth by heparin and its reversal by EGF. J. Cell. Physiol. 125:444-506.
9. Wright, T. C., Jr., L. A. Pukac, J. J. Castellot, Jr., M. J. Karnovsky, R. A. Levine, H. Y. Kim-Park, and J. Campisi. 1989. Heparin suppresses the induction of c-fos and c-myc mRNA in murine fibroblasts by selective inhibition of a protein kinase C-dependent pathway. Proc. Natl. Acad. Sci. USA 86:3199-3203.
10. Castellot, J. J., Jr., K. Wong, B. Herman, R. L. Hoover, D. F. Albertini, T. C. Wright, B. L. Caleb, and M. J. Karnovsky. 1985. Binding and internalization of heparin by vascular smooth muscle cells. J. Cell. Physiol. 124: 13-20.
11. Majesky, M. W., S. M. Schwartz, M. M. Clowes, and A. W. Clowes. 1987. Heparin regulates smooth muscle S phase entry in the injured rat carotid artery. Circ. Res. 61:296-300.
12. Castellot, J. J., Jr., L. A. Pukac, B. L. Caleb, T. C. Wright, and M. J. Karnovsky. 1989. Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells. J. Cell Biol. 109:3147-3155.
13. 1 phase of the cell cycle. J. Biol. Chem. 264:6990-6995.
14. Pukac, L. A., M. E. Ottlinger, and M. J. Karnovsky. 1992. Heparin suppresses specific second messenger pathways for protooncogene expression in rat vascular smooth muscle cells. J. Biol. Chem. 267:3707-3711.
15. Busch, S. J., G. A. Martin, R. L. Barnhart, M. Mano, A. D. Cardin, and R. L. Jackson. 1992. Trans-repressor activity of nuclear glycosaminoglycans on Fos and Jun/AP-1 oncoprotein-mediated transcription. J. Cell Biol. 116:31-42.
16. Au, Y. P. T., G. Dobrowolska, D. R. Morris, and A. W. Clowes. 1994. Heparin decreases activator protein-1 binding to DNA in part by posttranslational modification of Jun B. Circ. Res. 75:15-22.
17. + exchange and growth of PASMC. Am. J. Physiol. 270 (Lung Cell. Mol. Physiol. 14):L260-L265.
18. Akimoto, H., H. Ito, M. Tanaka, S. Adachi, M. Hata, M. Lin, H. Fujisaka, F. Marumo, and M. Hiroc. 1996. Heparin and heparin sulfate block angiotensin II-induced hypertrophy in cultured neonatal rat cardiomyocytes. Circulation 93:810-816.
19. Lee, S. L., W. W. Wang, J. J. Lanzillo, and B. L. Fanburg. 1994. Serotonin produces both hyperplasia and hypertrophy of bovine pulmonary artery smooth muscle cells in culture. Am. J. Physiol 266(Lung Cell. Mol. Physiol. 10):L46-L52.
20. Lee, S. L., W. W. Wang, and B. L. Fanburg. 1997. Association of tyrosine phosphorylation of GTPase-activating protein with mitogenic action of serotonin. Am. J. Physiol. 272(Cell Physiol. 41):C223-C230.
21. Lee, S. L., W. W. Wang, B. J. Moore, and B. L. Fanburg. 1991. Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture. Circ. Res. 68:1362-1368.
22. Lee, S. L., J. Dunn, F. S. Yu, and B. L. Fanburg. 1989. Serotonin uptake and configurational change of bovine pulmonary artery smooth muscle cells in culture. J. Cell. Physiol. 138:145-153.
23. Welham, M. J., and J. W. Schrader. 1992. Steel factor-induced tyrosine phosphorylation in murine mast cells. J. Immunol. 149:2772-2783.
24. 4. Nature 227:680-685.
25. Lee, S. L., J. Stevens, W. W. Wang, and J. J. Lanzillo. 1994. A liquid gelatin blocking reagent for Western blotting with chemiluminescent detection. BioTechniques 17:60-62.
26. 2 inhibit DNA synthesis in human airway smooth muscle cells in culture. Am. J. Physiol. 269(Lung Cell. Mol. Physiol. 13):L514-L519.
27. Lee, S. L., W. W. Wang, J. J. Lanzillo, and B. L. Fanburg. 1994. Regulation of serotonin-induced DNA synthesis of bovine pulmonary artery smooth muscle cells. Am. J. Physiol. 266(Lung Cell. Mol. Physiol. 10):L53-L60.
28. Ellis, C., M. Moran, F. McCormick, and T. Pawson. 1990. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Nature 343:377-381.
29. Lech-Lundberg, L. M. F., and X. H. Song. 1991. Bradykinin and bombesin rapidly stimulate tyrosine phosphorylation of a 120-KDa group of proteins in Swiss 3T3 cells. J. Biol. Chem. 266:7746-7749.
30. Zachary, I., J. Gil, W. Lehmann, J. Sinnett-Smith, and E. Rozengurt. 1991. Bombesin, vasopressin, and endothelin rapidly stimulate tyrosine phosphorylation in intact Swiss 3T3 cells. Proc. Natl Acad. Sci. USA 88:4577-4581.
31. Schvartz, L., O. Ittoop, G. Davidai, and E. Hazum. 1992. Endothelin rapidly stimulates tyrosine phosphorylation in osteoblast-like cells. Peptides 13:159-163.
32. Kanai, Y., S. Hori, T. Tanaka, M. Yasuoka, K. Watanabe, N. Aikawa, and Y. Hosoda. 1993. Role of 5-hydroxytryptamine in the progression of monocrotaline induced pulmonary artery in rats. Circ. Res. 27:1619-1623.
33. Hultgren, H. N., J. Kelly, and H. Miller. 1965. Pulmonary circulation in acclimatized man at high attitude. J. Appl. Physiol. 20:233-238.
34. Reid, L. 1979. The pulmonary circulation: remodeling in growth and disease. Am. Rev. Respir. Dis. 119:531-546.
35. Geisterfer, A. A. T., M. J. Peach, and G. K. Owens. 1988. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 62:749-756.
36. Geisterfer, A. A. T., and G. K. Owens. 1989. Arginine vasopressin-induced hypertrophy of cultured rat aortic smooth muscle cells. Hypertension 14: 413-420.
37. Mitsuhashi, M., and D. G. Payan. 1987. The mitogenic effects of vasoactive neuropeptides on cultured smooth muscle cells. Life Sci. 40:853-861.
38. Vanhoutte, P. M. 1983. 5-hydroxytryptamine and vascular disease. Federation Pro. 42:233-237.
39. Herve, P., L. Drouet, C. Dosquet, J. M. Launay, B. Rain, G. Simonneau, J. Caen, and P. Duroux. 1990. Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin. Am. J. Med. 89:117-120.
40. Herve, P., J. M. Lunay, M. L. Scrobohaci, F. Brenot, G. Simonneau, P. Petitpretz, P. Poubeau, J. Cerrina, P. Duroux, and L. Drouet. 1995. Increased plasma serotonin in primary pulmonary hypertension. Am. J. Med. 99:249-254.
41. Tschopp, T. B., and M. B. Zucker. 1972. Hereditary defect in platelet function in rats. Blood 40:217-226.
42. Sato, K., S. Webb, A. Tucker, M. Rabinovitch, R. F. O'Brien, I. F. McMurtry, and T. J. Stelzner. 1992. Factors influencing the idiopathic development of pulmonary hypertension in the Fawn Hooded rat. Am. Rev. Respir. Dis. 145:793-797.
43. Brenot, F., P. Herve, P. Petitpretz, F. Parent, P. Duroux, and G. Simonneau. 1993. Primary pulmonary hypertension and fenfluramine use. Br. Heart J. 70:537-541.
44. Castellot, J. J., Jr., J. Choay, J. C. Lormeau, M. Petitou, E. Sache, and M. J. Karnovsky. 1986. Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells. II. Evidence for a pentasaccharide sequence that contains a 3-o sulfate group. J. Cell Biol. 102:1979-1984.
45. Letourneur, D., B. L. Caleb, and J. J. Castellot. Jr. 1995. Heparin binding, internalization, and metabolism in vascular smooth muscle cells. I. Upregulation of heparin binding correlates with antiproliferative activity. J. Cell. Physiol. 165:676-686.
46. Barzu, T., M. Pascal, M. Maman, C. Roque, F. Lafont, and A. Rousselet. 1996. Entry and distribution of fluorescent antiproliferative heparin derivatives into rat vascular smooth muscle cells: comparison between heparin-sensitive and heparin-resistant cultures. J. Cell. Physiol. 167:8-21.
47. Reilly, C. F., L. M. S. Fritze, and R. D. Rosenberg. 1986. Heparin inhibition of smooth muscle cell proliferation: a cellular site of action. J. Cell. Physiol. 129:11-19.